MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-07-2026
Charles River Laboratories International Cash Conversion Cycle 2011-2026 | CRL
Annual Cash Conversion Cycle Charles River Laboratories International
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 65 | 67.7 | 67.7 | 64 | 65 | 70.6 | 82.4 | 91.8 | 96.2 | 88.7 | 97.4 | 97.1 | 96.6 | 94.1 | 87.9 | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 97.4 | 64 | 82.1 |
Quarterly Cash Conversion Cycle Charles River Laboratories International
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q3 | 2010-Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 68.2 | 67.4 | 68.5 | - | 97.3 | - | - | - | 91.8 | 88.3 | 68.3 | - | 35.5 | 32.7 | 66.9 | - | 66.4 | 62.6 | 68 | 71.3 | 75.8 | 82.6 | 73 | 67.9 | 70.2 | 71.3 | 74.4 | 71.6 | 73.6 | 73.6 | 83.3 | 82 | 84.5 | 83.6 | 81.3 | 71.2 | 78 | 76.5 | 81.5 | 69.6 | 70.5 | 72.6 | 75.2 | 71.4 | 71.9 | 69 | 72.9 | 69.6 | 68.9 | 68.7 | 66.4 | - | 66.5 | 65.1 | 61.9 | - | 60.8 | 58.5 | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 97.3 | 32.7 | 71.4 |
Cash Conversion Cycle of other stocks in the Diagnostics research industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
50.2 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Fulgent Genetics
FLGT
|
42.4 | $ 15.96 | 5.63 % | $ 483 M |  USA |
 |
Burning Rock Biotech Limited
BNR
|
149 | $ 16.76 | 1.09 % | $ 177 M |  China |
 |
Castle Biosciences
CSTL
|
31.6 | $ 19.83 | 3.07 % | $ 575 M | USA |
 |
Agilent Technologies
A
|
111 | $ 115.62 | -2.55 % | $ 35.1 B | USA |
|
Akumin
AKU
|
36.1 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Aspira Women's Health
AWH
|
1.01 K | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
364 | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
78.1 | - | -13.05 % | $ 7.29 M | USA |
 |
CareDx, Inc
CDNA
|
51.5 | $ 21.82 | 1.77 % | $ 1.16 B | USA |
 |
Chembio Diagnostics
CEMI
|
111 | - | 0.22 % | $ 16.8 M | USA |
 |
Lantheus Holdings
LNTH
|
97.3 | $ 93.06 | 2.26 % | $ 6.28 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
104 | - | -20.0 % | $ 1.06 M | USA |
 |
Medpace Holdings
MEDP
|
50.4 | $ 424.0 | -1.1 % | $ 12.2 B | USA |
 |
Co-Diagnostics
CODX
|
-2.46 K | $ 2.53 | 31.09 % | $ 3.37 M | USA |
 |
Myriad Genetics
MYGN
|
49.3 | $ 4.29 | 4.89 % | $ 397 M | USA |
 |
NeoGenomics
NEO
|
82.4 | $ 8.96 | -1.21 % | $ 1.15 B | USA |
 |
National Research Corporation
NRC
|
29.4 | $ 18.75 | 0.11 % | $ 420 M | USA |
 |
Global Cord Blood Corporation
CO
|
184 | - | - | $ 399 M | China |
 |
Genetic Technologies Limited
GENE
|
11 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
142 | - | 0.12 % | $ 80.1 M | China |
 |
Natera
NTRA
|
81.5 | $ 194.24 | -11.64 % | $ 19.1 B | USA |
 |
DermTech
DMTK
|
66.7 | - | -11.32 % | $ 2.94 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.21 K | - | - | $ 10.7 B | USA |
 |
Enzo Biochem
ENZ
|
154 | - | -8.98 % | $ 14.8 K | USA |
 |
Koninklijke Philips N.V.
PHG
|
89 | $ 27.21 | 0.18 % | $ 25.8 B |  Niderland |
 |
Exact Sciences Corporation
EXAS
|
42.5 | - | - | $ 19.8 B | USA |
 |
Personalis
PSNL
|
-1.89 | $ 5.98 | -0.17 % | $ 534 M | USA |
 |
Guardant Health
GH
|
79.6 | $ 95.7 | 3.73 % | $ 12 B | USA |
 |
Senseonics Holdings
SENS
|
36.1 | $ 5.03 | -6.16 % | $ 210 M | USA |
 |
Soleno Therapeutics
SLNO
|
-398 | $ 52.95 | - | $ 2.69 B | USA |
 |
Heska Corporation
HSKA
|
138 | - | - | $ 1.31 B | USA |
 |
ICON Public Limited Company
ICLR
|
62 | $ 124.49 | -0.41 % | $ 10.3 B |  Irlanda |
 |
Illumina
ILMN
|
142 | $ 141.88 | 2.29 % | $ 22.6 B | USA |
 |
Interpace Biosciences
IDXG
|
62.9 | $ 1.95 | -2.5 % | $ 8.63 M | USA |
 |
QIAGEN N.V.
QGEN
|
122 | - | - | $ 10.6 B | Niderland |
 |
Trinity Biotech plc
TRIB
|
136 | $ 0.61 | 2.52 % | $ 219 M | Irlanda |
 |
Twist Bioscience Corporation
TWST
|
83.6 | $ 56.85 | -2.89 % | $ 3.4 B | USA |
 |
Biomerica
BMRA
|
172 | $ 2.15 | -2.05 % | $ 4.94 M | USA |
 |
Thermo Fisher Scientific
TMO
|
70 | $ 465.0 | -1.99 % | $ 175 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
40.3 | $ 254.12 | -1.52 % | $ 21.1 B | USA |
 |
Motus GI Holdings
MOTS
|
3.45 K | - | -34.28 % | $ 263 K |  Israel |
 |
Waters Corporation
WAT
|
731 | $ 355.13 | 1.32 % | $ 21.1 B | USA |
 |
Neogen Corporation
NEOG
|
150 | $ 9.05 | -2.16 % | $ 1.96 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
39.5 | $ 187.39 | -1.82 % | $ 20.8 B | USA |